Article info
PDFClinical science
Original article
Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy
- Correspondence to J N Sahni, St Paul's Eye Unit, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, UK; jayashreesahni{at}yahoo.co.uk
Citation
Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy
Publication history
- Accepted May 24, 2010
- First published October 11, 2010.
Online issue publication
March 17, 2011
Article Versions
- Previous version (11 October 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.